Bioactivity of human GM-CSF gene therapy in metastatic renal cell carcinoma and prostate cancer.
Simons
J W
JW
Brady Urological Institute, Johns Hopkins Oncology Center, Baltimore, MD, USA.
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D015316:Genetic Therapy; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics*; D006801:Humans; D006968:Hypersensitivity, Delayed; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D013601:T-Lymphocytes / Q000276:immunology
D019496:Cancer Vaccines; D016178:Granulocyte-Macrophage Colony-Stimulating Factor